<table sstyle="width:80%" align="center" border=1>
<tr>
<th>mv</th>
<th>dw</th>
<th>HMMCrowd</th>
</tr>
<tr>
<td width=33%>
[99, 105] serotonin uptake inhibitor fluvoxamine maleate.<br></td>
<td width=33%>
[90, 93] placebo-controlled<br>[99, 105] serotonin uptake inhibitor fluvoxamine maleate.<br></td>
<td width=33%>
[5, 7] placebo-<br>[10, 11] fluvoxamine<br>[90, 93] placebo-controlled<br>[96, 105] potent and selective serotonin uptake inhibitor fluvoxamine maleate.<br>[105, 123] Behavioral ratings were obtained at baseline and after 4, 8, and 12 weeks of treatment.<br>[135, 137] fluvoxamine-<br>[150, 151] placebo<br>[162, 163] placebo<br>[260, 261] Fluvoxamine<br>[265, 266] placebo<br>[284, 285] fluvoxamine<br></td>
</tr>
